Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02676466 · ClinicalTrials.gov registry record · Phase 2

The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study

A Phase 2 study of Inflammation, sponsored by University of Florida.

Completed
Registry status
Phase 2
Development phase
289
Enrollment target
5
Study locations

NCT02676466 is a Phase 2 study of Inflammation that has completed, run by University of Florida. The registered enrollment target is 289 participants, roughly in line with the 286-participant average among 132 other Inflammation trials with a reported enrollment target. The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02676466, a Phase 2 study of Inflammation, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 2
Development phase
289 participants
Enrollment target
5
Study locations

Study Summary

ENRGISE Pilot Study will test the ability of anti-inflammatory interventions for preventing major mobility disability by improving or preserving walking ability.

Conditions Studied

Inflammation

Interventions

  • DRUG Losartan
  • DIETARY_SUPPLEMENT Omega-3 fish oil
  • OTHER Corn Oil (Fish oil Placebo)
  • OTHER Cellulose Based (Losartan Placebo)

Study Locations (5)

Florida

  • University of Florida - Gainesville

Illinois

  • Northwestern University - Chicago

Massachusetts

  • Tufts University - Boston

North Carolina

  • Wake Forest University - Winston-Salem

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 289 participants
Start Date 2016-04-26
Est. Completion 2018-06-22
Phase Phase 2

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02676466

The ClinicalTrials.gov registry entry for NCT02676466 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 286-participant average among 132 other Inflammation trials with a reported enrollment target. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 4 interventions - of which Losartan is the first listed.

NCT02676466 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Illinois, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02676466 about?

NCT02676466 is a clinical study titled "The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study". ENRGISE Pilot Study will test the ability of anti-inflammatory interventions for preventing major mobility disability by improving or preserving walking ability.

What is the current status of trial NCT02676466?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 289 participants. The study started on 2016-04-26. Estimated completion is 2018-06-22.

What conditions does trial NCT02676466 study?

This clinical trial studies the following conditions: Inflammation.

What interventions are being tested in trial NCT02676466?

The interventions under investigation include: Losartan (DRUG), Omega-3 fish oil (DIETARY_SUPPLEMENT), Corn Oil (Fish oil Placebo) (OTHER), Cellulose Based (Losartan Placebo) (OTHER).

Who is sponsoring clinical trial NCT02676466?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02676466 being conducted?

This trial has 5 study locations across Florida, Illinois, Massachusetts, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Inflammation

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.